Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for general anesthesia in elective laparoscopic surgery
ChiCTR2100053855Phase 3Recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of esketamine (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Hamilton Depression Scale and Fully awake time. Started Nov 2021; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2100053855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100053855.